PRCO(SZ:002225) EBSCN·2025-10-28 07:15Investment Rating - The report maintains an "Accumulate" rating for the company [5]. Core Views - The main business of the company is under pressure, affecting its operational performance. The company reported a revenue of 4.18 billion yuan and a net profit attributable to shareholders of 90 million yuan for the first three quarters of 2025, reflecting a year-on-year change of +4.3% for revenue and -22.8% for net profit [1]. - The gross margin has declined to 17.6%, down 1.0 percentage points year-on-year, primarily due to weak demand and reduced settlement prices from customers. The net profit margin for the third quarter was 1.8%, an increase of 2.8 percentage points year-on-year [2][3]. - Accounts receivable have increased by 20.1% year-on-year, indicating slower customer payments, while operating cash flow for the third quarter decreased by 67.7% year-on-year [3]. - The company has signed a supplementary strategic agreement with a partner, enhancing the demand certainty for its active magnesium oxide products. However, due to short-term disruptions in the release of magnesium oxide and slow customer payments in the main business, the net profit forecasts for 2025-2027 have been revised downwards [3]. Summary by Sections Financial Performance - For the first three quarters of 2025, the company achieved a revenue of 4.18 billion yuan, a net profit of 90 million yuan, and a net profit excluding non-recurring items of 70 million yuan, with respective year-on-year changes of +4.3%, -22.8%, and -4.6% [1]. - The gross margin for the first three quarters was 17.6%, down 1.0 percentage points year-on-year, while the net profit margin was 2.3%, down 0.7 percentage points year-on-year [2]. Cash Flow and Receivables - As of the end of Q3, accounts receivable stood at 2.35 billion yuan, up 20.1% year-on-year, indicating a slowdown in customer payments. The operating cash flow for Q3 was 40 million yuan, down 67.7% year-on-year [3]. Profit Forecast and Valuation - The profit forecasts for 2025-2027 have been adjusted to 144 million yuan, 419 million yuan, and 628 million yuan, reflecting decreases of 53%, 23%, and 17% respectively from previous estimates. The report maintains an "Accumulate" rating despite these adjustments [3].